These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31964364)

  • 21. Coreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominates.
    Phuphuakrat A; Phawattanakul S; Pasomsub E; Kiertiburanakul S; Chantratita W; Sungkanuparph S
    HIV Med; 2014 May; 15(5):269-75. PubMed ID: 24215399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
    Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
    J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection.
    Uprety P; Patel K; Karalius B; Ziemniak C; Chen YH; Brummel SS; Siminski S; Van Dyke RB; Seage GR; Persaud D;
    Clin Infect Dis; 2017 Jun; 64(11):1471-1478. PubMed ID: 28329153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
    Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D;
    J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
    Yam WC; Chen JH; Wong KH; Chan K; Cheng VC; Lam HY; Lee SS; Zheng BJ; Yuen KY
    J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy.
    Cuzin L; Pugliese P; Sauné K; Allavena C; Ghosn J; Cottalorda J; Rodallec A; Chaix ML; Fafi-Kremer S; Soulié C; Ouka M; Charpentier C; Bocket L; Mirand A; Guiguet M;
    AIDS; 2015 Aug; 29(13):1665-71. PubMed ID: 26372277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A higher CD4/CD8 ratio correlates with an ultralow cell-associated HIV-1 DNA level in chronically infected patients on antiretroviral therapy: a case control study.
    Yue Y; Wang N; Han Y; Zhu T; Xie J; Qiu Z; Song X; Li Y; Routy JP; Wang J; Li T
    BMC Infect Dis; 2017 Dec; 17(1):771. PubMed ID: 29246197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China.
    Li X; Xue Y; Zhou L; Lin Y; Yu X; Wang X; Zhen X; Zhang W; Ning Z; Yue Q; Fu J; Shen F; Gai J; Xu Y; Mao J; Gao X; Shen X; Kang L; Vanham G; Cheng H; Wang Y; Zhuang M; Zhuang X; Pan Q; Zhong P
    PLoS One; 2014; 9(2):e89462. PubMed ID: 24586795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.
    Lam EP; Moore CL; Gotuzzo E; Nwizu C; Kamarulzaman A; Chetchotisakd P; van Wyk J; Teppler H; Kumarasamy N; Molina JM; Emery S; Cooper DA; Boyd MA
    AIDS Res Hum Retroviruses; 2016 Sep; 32(9):841-50. PubMed ID: 27346600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Subtype Shift in the Philippines is Associated With High Transmitted Drug Resistance, High Viral Loads, and Fast Immunologic Decline.
    Salvaña EMT; Dungca NT; Arevalo G; Li K; Francisco C; Penalosa C; Dela Tonga A; Leyritana K; Solante R; Tactacan-Abrenica RJ; Lim J; Alejandria M; Palaypayon N; Schwem B
    Int J Infect Dis; 2022 Sep; 122():936-943. PubMed ID: 35788414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy.
    Masquelier B; Taieb A; Reigadas S; Marchou B; Cheneau C; Spire B; Charpentier C; Leport C; Raffi F; Chêne G; Descamps D;
    J Antimicrob Chemother; 2011 Jul; 66(7):1582-9. PubMed ID: 21525020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens.
    Bunupuradah T; Ananworanich J; Chetchotisakd P; Kantipong P; Jirajariyavej S; Sirivichayakul S; Munsakul W; Prasithsirikul W; Sungkanuparph S; Bowonwattanuwong C; Klinbuayaem V; Petoumenos K; Hirschel B; Bhakeecheep S; Ruxrungtham K
    Antivir Ther; 2011; 16(7):1113-21. PubMed ID: 22024527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 DNA concentrations and evolution among African HIV-1-infected children under antiretroviral treatment (ANRS 1244/1278).
    Boullé C; Rouet F; Fassinou P; Msellati P; Debeaudrap P; Chaix ML; Rouzioux C; Avettand-Fenoel V
    J Antimicrob Chemother; 2014 Nov; 69(11):3047-50. PubMed ID: 25038068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA.
    Laanani M; Ghosn J; Essat A; Melard A; Seng R; Gousset M; Panjo H; Mortier E; Girard PM; Goujard C; Meyer L; Rouzioux C;
    Clin Infect Dis; 2015 Jun; 60(11):1715-21. PubMed ID: 25737374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART.
    Lombardi F; Belmonti S; Rapone L; Borghetti A; Ciccullo A; Gagliardini R; Baldin G; Montagnani F; Moschese D; Emiliozzi A; Rossetti B; De Luca A; Di Giambenedetto S
    J Clin Virol; 2018 Jun; 103():57-62. PubMed ID: 29656086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy.
    Palmisano L; Giuliano M; Chiarotti F; Zanchetta M; Andreotti M; Pirillo MF; Riva E; Antonelli G; De Rossi A; Vella S
    J Acquir Immune Defic Syndr; 2008 May; 48(1):68-71. PubMed ID: 18360287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spread of HIV-1 subtypes B and CRF01_AE among injecting drug users in Bangkok, Thailand.
    Xiridou M; van Griensven F; Tappero JW; Martin M; Gurwith M; Vanichseni S; Kittikraisak W; Coutinho R; Choopanya K
    J Acquir Immune Defic Syndr; 2007 Aug; 45(4):468-75. PubMed ID: 17496560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.
    Easterbrook PJ; Smith M; Mullen J; O'Shea S; Chrystie I; de Ruiter A; Tatt ID; Geretti AM; Zuckerman M
    J Int AIDS Soc; 2010 Feb; 13():4. PubMed ID: 20205896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid identification of human immunodeficiency virus type 1 CRF01_AE and BC recombinants by subtype-specific PCR.
    Luo H; Su QJ; Shao YM; Xing H; Chen J; Liu W; Zhang ZY; Zang N; Xiao X; Liang H
    J Virol Methods; 2011 Feb; 171(2):339-44. PubMed ID: 21126539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular characteristics of HIV-1 CRF01 _ AE strains in Zhejiang province].
    Yao YP; Xin RL; He X; Meng ZF; Pan XH; Guo ZH; Yang JZ; Xu Y; Xing H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Feb; 29(2):161-5. PubMed ID: 18686858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.